Peer Review History
| Original SubmissionJanuary 4, 2025 |
|---|
|
PPATHOGENS-D-25-00024 Stylet cuticular gene-directed mutagenesis impairs the pea aphid vector capacity to transmit a plant virus PLOS Pathogens Dear Dr. Uzest, Thank you for submitting your manuscript to PLOS Pathogens. After careful consideration, we feel that it has merit but does not fully meet PLOS Pathogens's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days Jun 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plospathogens@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/ppathogens/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Christophe Ritzenthaler Academic Editor PLOS Pathogens Savithramma Dinesh-Kumar Section Editor PLOS Pathogens Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 Journal Requirements: 1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019. 2) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©, ®, or TM (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including: - ® on pages: 24 and 27. 3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plospathogens/s/figures 4) We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 5) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form. Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager. Potential Copyright Issues: - Please confirm (a) that you are the photographer of Figure 1A, and 5, or (b) provide written permission from the photographer to publish the photo(s) under our CC BY 4.0 license. 6) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well. State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM).". If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d Reviewers' Comments: Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: The manuscript describes an extensive analysis of Cas9 mutants of the stylet proteins which participate in CaMV virus transmission. The results are internally consistent and appropriate. The novelty of this work is repeatedly noted – though the generation of the mutants was previously published. The authors have done a good job of making quantitative presentation of qualitative observations. Reviewer #2: Aphids are serious agricultural pests, notorious for transmitting hundreds of plant viruses, including Cauliflower mosaic virus (CaMV). CaMV transmission by aphids relies on a helper mechanism involving the viral non-structural protein P2 and its receptors on the surface of the acrostyle, a specialized structure at the tip of the insect’s stylet. Stylin proteins are prime candidates for these receptors. In their study, Fu et al. developed two mutant aphid lines with edits to the Stylin-01 gene: one is a complete knockout, and the other produces a modified version of the protein with changes to its exposed C-terminal domain. Using these mutants, the researchers showed that fully functional Stylin-01 is essential for efficient CaMV transmission by aphids. This research significantly enhances our understanding of the critical role this cuticular component plays in plant-virus-vector interactions. This manuscript is well-written and only a few minor modifications and discussion are required. Reviewer #3: The long-standing question of the biochemical basis of how plant viruses are transmitted by insects to the host plant is key to the development of new, environmentally approaches to controlling their transmission. These viruses can replicate within the insect host while others have a direct transmission route from infected stylets or other mouthparts. Previous studies had used RNAi approaches to down-regulate target genes however these are, by nature, transient, variable and somewhat inconclusive. Here the authors utilized two previously generated CRISPR/Cas9 mutants in a stylet gene to determine the role of this gene in virus transmission. One was essentially a completely dysfunctional mutation whole the second had retained most of the amino-terminal sequence but has lost the carboxy-terminal domain. The experiments were well conducted and clearly show the role that the stylin-1 gene plays in transmission of the virus. They implicate the ability of the acrostyle to successfully bind the P2 protein of the virus and also show up-regulation effects on another stylin in these mutants. I recommend the manuscript be accepted. It is short and concise, but will be of significant interest in the field. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: The raw data for the figures should be made available via a data repository, or provided as a supplemental spreadsheet / document. This is particularly true given the nature of statistical packages used for the analysis. Reviewer #2: 1. In lines 119-121, the authors mention that the Sty01-Cter line lacks the 11 C-terminal amino acids that form the surface-exposed domain of the acrostyle, which is thought to interact with viruses. Did the researchers test whether this domain is essential for binding to CaMV? To properly verify this interaction, co-immunoprecipitation (Co-IP) or immunofluorescence co-localization experiments should have been conducted. 2. Fig 3 demonstrates a reduction in the number of positively labeled stylets for both mutant lines compared to WT aphids. However, it appears that a significant majority of the mutant aphids (over 80%) still retain the ability to bind CaMV P2 proteins and thus can transmit the virus. This raises the question of whether Stylin-01 is indeed the most critical protein regulating viral transmission. While the gene knockout has a statistically significant effect, the impact on virus transmission does not seem substantial enough to conclusively establish Stylin-01 as the primary regulator. This observation suggests that other factors or proteins might also play crucial roles in CaMV transmission, which deserves discussion. Reviewer #3: (No Response) ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: The writing style is at times cumbersome with excessive use of comas and prepositions. The PDF is provided with several dozen suggested edits. The presentation of statistical includes non-parametric tests associated with non-normal distribution. Additional detail, including the assessment of normality would seem appropriate, even though the work understandably has limited numbers (making normality tests problematic). This statistical analysis seems to rely on the authors use of packages, more so than an understanding of the underlying statistical tests. The discussion is quite redundant with the results, including reiterated references to the figures rather than extending the analysis to a broader perspective. This section could be considerably shortened. The effort made in high quality presentation of graphics and tables (including supplemental) is noted. The overall quality and quantity of research represents a excellent addition to the literature. Reviewer #2: 1. The antibodies used for western blotting and immunofluorescent localization, particularly those against Sty01-Cter and Sty01-KO in Fig 1, 3, and 5, should be clearly indicated either in the figures themselves or thoroughly described in the figure legends. This will help readers better understand and interpret the data presented in the figures. 2. Fig 3B presents the number of stylets observed for each group from a single experiment batch. To establish the reproducibility of these results, it is a standard practice to conduct at least 3 independent experimental batches. Without multiple batches, the results may lack statistical significance and robustness. It is crucial to know whether the authors conducted different experimental batches to validate their findings. Reviewer #3: (No Response) ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Wayne R. Curtis Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols
|
| Revision 1 |
|
Dear Dr Uzest, We are pleased to inform you that your manuscript 'Stylet cuticular gene-directed mutagenesis impairs the pea aphid vector capacity to transmit a plant virus' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Christophe Ritzenthaler Academic Editor PLOS Pathogens Savithramma Dinesh-Kumar Section Editor PLOS Pathogens Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 *********************************************************** Reviewer Comments (if any, and for reference): |
| Formally Accepted |
|
Dear Dr Uzest, We are delighted to inform you that your manuscript, "Stylet cuticular gene-directed mutagenesis impairs the pea aphid vector capacity to transmit a plant virus," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .